Intellectual property right in India - A review Hussain Shaik Md. Zakir1,*, Shiva Jennai2, Venkateswarlu Goli3, Suthakaran R.4, Ghouse Syed5 1Department of Pharmaceutics, Smt Sarojini Ramulamma College of Pharmacy-Mahabubnagar, Telangana, India 2Department of Pharmaceutics, Vijaya College of Pharmacy, Hayathnagar (m), Hyderabad, Telangana, India 3Department of Pharmaceutical Biotechnology, Vijaya College of Pharmacy, Hayathnagar (m), Hyderabad, Telangana, India 4Department of Pharmaceutical Analysis, Vijaya College of Pharmacy, Hayathnagar (m), Hyderabad, Telangana, India 5Department of Pharmaceutical Chemistry, Vijaya College of pharmacy, Hayathnagar (m), Hyderabad, Telangana, India *Corresponding author Tel.: +91-8639704428, E-mail address: zakirhussains765@gmail.com (Z. Hussain)
Online published on 24 May, 2021. Abstract The CDSCO prescribes standards and measures for ensuring the safety, efficacy and quality of drugs, diagnostics, cosmetics and devices in the country. Pharmaceutical research and development is an expensive, time consuming and uncertain process that may take 8-10 years to complete. Patent clock starts much before a new drug is approved for marketing and significant amount of time may be lost in the review and approval process by regulatory bodies. So in order to recoup the considerable time and resources invested in the drug development and approval process, the pharmaceutical companies depend on exclusivity provisions granted by the regulatory bodies. Patent strategy provides a check list for developing comprehensive patent strategies for the company. Top Keywords Patent, TRIPS, Intellectual property right, Designs and Trade Marks. Top |